Abstract:With the rapid development of the fields of tumor biology and immunology, tumor immunotherapy has been used in clinical practice and has demonstrated significant therapeutic potential, particularly for treating tumors that do not respond to standard treatment options. Despite its advances, immunotherapy still has limitations, such as poor clinical response rates and differences in individual patient responses, largely because tumor tissues have strong immunosuppressive microenvironments. Many tumors have a tumor microenvironment (TME) that is characterized by hypoxia, low pH, and substantial numbers of immunosuppressive cells, and these are the main factors limiting the efficacy of antitumor immunotherapy. The TME is crucial to the occurrence, growth, and metastasis of tumors. Therefore, numerous studies have been devoted to improving the effects of immunotherapy by remodeling the TME. Effective regulation of the TME and reversal of immunosuppressive conditions are effective strategies for improving tumor immunotherapy. The use of multidrug combinations to improve the TME is an efficient way to enhance antitumor immune efficacy. However, the inability to effectively target drugs decreases therapeutic effects and causes toxic side effects. Nanodrug delivery carriers have the advantageous ability to enhance drug bioavailability and improve drug targeting. Importantly, they can also regulate the TME and deliver large or small therapeutic molecules to decrease the inhibitory effect of the TME on immune cells. Therefore, nanomedicine has great potential for reprogramming immunosuppressive microenvironments and represents a new immunotherapeutic strategy. Therefore, this article reviews strategies for improving the TME and summarizes research on synergistic nanomedicine approaches that enhance the efficacy of tumor immunotherapy. Graphical Download : Download high-res image (225KB) Download : Download full-size image Overview of strategies for reshaping the tumor microenvironment and improving the efficacy of immunotherapy based on nanomedicine and nanodelivery systems.

Nanoparticles for Modulating Tumor Microenvironment to Improve Drug Delivery and Tumor Therapy

Smart Nanoparticles for Breast Cancer Treatment Based on the Tumor Microenvironment

Nanoparticle-Mediated Targeted Drug Delivery to Remodel Tumor Microenvironment for Cancer Therapy

Nanoparticles Targeting and Remodeling Tumor Microenvironment for Cancer Theranostics.

Tumor Microenvironment Regulation and Cancer Targeting Therapy Based on Nanoparticles

Nanotherapy Targeting the Tumor Microenvironment

Nanomedicine for tumor microenvironment modulation and cancer treatment enhancement

Tumor Microenvironment‐Enabled Nanotherapy

Shaping Tumor Microenvironment for Improving Nanoparticle Delivery

Remodeling the Tumor Microenvironment with Emerging Nanotherapeutics

Modulating the Tumor Microenvironment to Enhance Tumor Nanomedicine Delivery

Tumor Microenvironment Modulating Functional Nanoparticles for Effective Cancer Treatments

Engineered Drug Delivery Nanosystems for Tumor Microenvironment Normalization Therapy

The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment

Overcoming the Biological Barriers in the Tumor Microenvironment for Improving Drug Delivery and Efficacy

Tumor microenvironment responsive metal nanoparticles in cancer immunotherapy

Tumour Microenvironment Responsive Nanoconstructs for Cancer Theranostic

Tumor microenvironment reprogramming by nanomedicine to enhance the effect of tumor immunotherapy

Emerging Nanomedicines Strategies Focused on Tumor Microenvironment Against Cancer Recurrence and Metastasis

Modulation of Tumor Microenvironment for Immunotherapy: Focus on Nanomaterial-Based Strategies

Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy